# Exploring the Anticancer Properties of 1,2,3-Triazole-Substituted Andrographolide Derivatives

**Authors:** Joana R. L. Ribeiro, Juliana Calheiros, Rita A. M. Silva, Bruno M. F. Gonçalves, Carlos A. M. Afonso, Lucília Saraiva, Maria-José U. Ferreira

PMC · DOI: 10.3390/ph18050750 · Pharmaceuticals · 2025-05-19

## TL;DR

Researchers synthesized and tested new andrographolide derivatives with triazole groups, finding some to be effective at stopping cancer cell growth and inducing cell death.

## Contribution

The study introduces novel triazole-substituted andrographolide derivatives with enhanced anticancer activity and explores their mechanisms.

## Key findings

- Compounds 9, 14, 16, and 17 showed improved antiproliferative activity compared to the parent compound.
- Derivative 12 induced G2/M cell cycle arrest and apoptosis in PANC-1 cells.
- Compound 12 reduced cell migration and synergized with 5-fluorouracil in pancreatic cancer cells.

## Abstract

Background/Objectives: The search for new anticancer agents from natural sources remains a key strategy in drug discovery. This study aimed to synthesize and evaluate novel triazole derivatives of the diterpenic lactone andrographolide for their antiproliferative activity against various cancer cell lines. Methods: Twenty-two new triazole derivatives (5–26), of the triacetyl derivative (2) of the diterpenic lactone andrographolide (1), were synthesized via the azide-alkyne “click reaction”. The antiproliferative effects of compounds 1–26 were evaluated using the sulforhodamine B assay against a panel of cancer cell lines and a non-tumorigenic colon cell line. A representative compound, triazole derivative 12, was further evaluated in human pancreatic ductal adenocarcinoma (PANC-1) cells for its effects on the cell cycle, apoptosis, migration, and drug synergy with 5-fluorouracil. Results: Several compounds, specifically, 9, 14, 16, and 17, bearing a phenyl moiety, exhibited improved antiproliferative activity compared to the parental compound 1. Derivative 12, selected for further investigation, induced G2/M cell cycle arrest and apoptosis in a concentration-dependent manner. Additionally, this compound significantly reduced cell migration and demonstrated synergistic effects with 5-fluorouracil in PANC-1 cells. Conclusions: The synthesized andrographolide-based triazole derivatives, particularly compound 12, showed promising antiproliferative activity and mechanisms relevant to cancer therapy. These findings support their potential as lead compounds for further development in anticancer research.

## Linked entities

- **Chemicals:** andrographolide (PubChem CID 5318517), 5-fluorouracil (PubChem CID 3385)
- **Diseases:** cancer (MONDO:0004992), pancreatic ductal adenocarcinoma (MONDO:0005184)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** cancer (MESH:D009369), pancreatic ductal adenocarcinoma (MESH:D021441)
- **Chemicals:** triazole (MESH:D014230), 1,2,3-Triazole (-), azide (MESH:D001386), 5-fluorouracil (MESH:D005472), alkyne (MESH:D000480), sulforhodamine B (MESH:C022027), Andrographolide (MESH:C030419)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PANC-1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12114840/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12114840/full.md

## References

60 references — full list in the complete paper: https://tomesphere.com/paper/PMC12114840/full.md

---
Source: https://tomesphere.com/paper/PMC12114840